Emerging Companies on the Rise
Fortune India’s The Next 500 event showed how emerging companies are scaling new levels.
Fortune India’s The Next 500 event showed how emerging companies are scaling new levels.
Among diagnostics companies, Vijaya Diagnostic Centre topped the gainers’ chart, followed by Dr. Lal PathLabs, Metropolis Healthcare, and Thyrocare Technologies.
Dr. Lal Pathlabs has reported a 27% YoY fall in consolidated net profit to ₹62 crore in Q4FY22 due to a decline in revenue from Covid and allied business.
Ameera Shah's Metropolis Healthcare is all set to acquire Hitech Diagnostics Centre. Here's Fortune India's earlier story on how Shah is transforming her fast-growing pathlab company.
By holding itself accountable to committed results and highest governance standards, Metropolis hopes to attract and retain the support of marquee investors for future growth.
Global PE major TA Associates, which completed nine years in India, is focussed on making more investments here, particularly in the areas of technology, and consumer and financial services.
From 10 clinical labs in 2005, Dr Lal PathLabs has become the largest diagnostic chain in north India and is looking to expand to the eastern and southern markets. Can it sustain its momentum?